Document:

Amended and Restated 2003 Stock Option Plan

 Exhibit 10.18 
  
 M-Foods Holdings, Inc. 
  

Amended and Restated 
 2003 Stock
Option Plan 
  
 SECTION 1. Purpose. The purposes of the
M-Foods Holdings, Inc. Amended and Restated 2003 Stock Option Plan (the “Plan”) are to promote the interests of M-Foods Holdings, Inc. and its direct and indirect stockholders by (i) attracting and retaining exceptional officers and key
employees to the Company and its Subsidiaries and (ii) enabling such individuals to participate in the long-term growth and financial success of the Company and its Subsidiaries. The Plan is a compensatory benefit plan within the meaning of Rule 701
of the Securities Act and, unless and until the Company is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the issuance of options to purchase Common Stock pursuant to the Plan and the issuance of Common Stock
pursuant to such options is intended to qualify for the exemption from registration under the Securities Act provided by Rule 701. Grants of “nonqualified stock options” or “incentive stock options” may be made under the Plan.

  
 SECTION 2. Definitions. As used in the Plan, the
following terms shall have the meanings set forth below: 
  
 “Affiliate” shall mean any entity that, directly or indirectly, is controlled by, controls or is under common control with, the Company. 
  
 “Award Agreement” shall mean any written agreement, contract, or other instrument or document
evidencing any Option, which may, but need not, be executed or acknowledged by a Participant. 
  
 “Board” shall mean the Board of Directors of the Company. 
  
 “Cause” shall have the meaning set forth in a Participant’s Management Unit Subscription
Agreement. If the Participant has not entered into a Management Unit Subscription Agreement, “Cause” shall have the same meaning ascribed to such term in any employment or severance agreement then in effect between Participant and the
Company or one of its Subsidiaries or, if no such agreement containing a definition of “Cause” is then in effect, shall mean (i) the continued failure of the Participant to perform substantially the Participant’s duties with the
Company or one of its Affiliates (other than any such failure resulting from incapacity due to physical or mental illness), after a written demand for substantial performance is delivered to the Participant by the Board which specifically identifies
the manner in which the Board believes that the Participant has not substantially performed the Participant’s duties; (ii) the engaging by the Participant in illegal conduct or gross misconduct which is materially and demonstrably injurious to
the Company or one of its Affiliates; or (iii) the indictment, prosecution or conviction of a felony or guilty or nolo contendere plea by the Participant with respect thereto. 

 “Code” shall mean the Internal Revenue Code of 1986, as amended from time to
time. 
  
 “Committee” shall mean the
compensation committee of the Board, or such other committee of the Board as may be designated by the Board to administer the Plan. 
  
 “Common Stock” shall mean shares of common stock of the Company, par value $.01 per share. 
  
 “Company” shall mean M-Foods Holdings, Inc., a
Delaware corporation, and (except to the extent the context requires otherwise) any subsidiary company of M-Foods Holdings, Inc. as such term is defined in Section 424(f) of the Code. 
  
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 
  
 “Fair Market Value” unless otherwise defined in
Participant’s Award Agreement, shall mean the fair value of the Common Stock as determined in good faith by the Committee (without taking into account the effect of any contemporaneous repurchase of Common Stock at less than Fair Market Value
under a Company repurchase right). 
  
 “Investors” shall mean Michael Foods Investors, LLC, a Delaware limited liability company. 
  
 “Management Unit Subscription Agreement” shall mean any Management Unit Subscription Agreement between Investors and the
Participant, unless the Participant has not entered into a Management Stock Purchase and Unit Subscription Agreement. 
  
 “Option” shall mean a right to purchase Option Shares from the Company that is granted under Section 6 of the Plan. 

 
 “Option Shares” shall mean (i) shares of Common
Stock granted pursuant to the Plan, (ii) all adjusted shares of Common Stock received as a result of adjustments pursuant to Section 4(b) hereof or (iii) all shares of Common Stock issued with respect to the Common Stock referred to in clause (i)
above by way of stock dividend or stock split or in connection with any conversion, merger, consolidation or recapitalization or other reorganization affecting the Common Stock. Option Shares shall continue to be Option Shares in the hands of any
holder other than the Participant (except for the Company), and each such transferee thereof shall succeed to the rights and obligations of a holder of Option Shares hereunder. 
  
 “Participant” shall mean any officer or key employee of the Company or its Subsidiaries who has
been selected to participate in the Plan by the Committee or the Board. A Person shall remain a Participant under this Plan as long as such Person holds Options or Option Shares. 
  

 2 

 “Person” shall mean any individual, corporation, partnership, limited liability
company, association, joint-stock company, trust, unincorporated organization, government or political subdivision thereof or other entity. 
  
 “Plan” shall mean this M-Foods Holdings, Inc. Amended and Restated 2003 Stock Option Plan. 
  
 “Public Offering” means a sale of Common Stock to
the public in an offering pursuant to an effective registration statement filed with the SEC pursuant to the Securities Act, as then in effect, provided that a Public Offering shall not include an offering made in connection with a business
acquisition or combination or an employee benefit plan. 
  
 “Sale of the Company” means the consummation of a transaction, whether in a single transaction or in a series of related transactions that are consummated contemporaneously (or consummated pursuant to
contemporaneous agreements), with any other Person or group of related Persons on an arm’s-length basis other than an affiliate of THL, pursuant to which such party or parties (a) acquire (whether by merger, stock purchase, recapitalization,
reorganization, redemption, issuance of capital stock or otherwise) more than 50% of the voting stock of the Company or (b) acquire assets constituting all or substantially all of the assets of the Company and its Subsidiaries on a consolidated
basis; provided, however, that in no event shall a Sale of the Company be deemed to include any transaction effected for the purpose of (i) changing, directly or indirectly, the form of organization or the organizational structure of the Company or
any of its Subsidiaries or (ii) contributing stock to entities controlled by the Company. 
  
 “SEC” shall mean the Securities and Exchange Commission or any successor thereto and shall include the staff thereof.

  
 “Securities Act” shall mean the
Securities Act of 1933, as amended. 
  
 “Subsidiary” shall mean any entity that, directly or indirectly, is controlled by the Company. 
  
 “THL” shall mean Thomas H. Lee Equity Fund V, L.P., and any of its Affiliates. 
  
 SECTION 3. Administration. (a) The Plan shall be administered by the
Committee. Subject to the terms of the Plan, any Award Agreement and applicable law, and in addition to other express powers and authorizations conferred on the Committee by the Plan, the Committee shall have full power and authority to: (i)
designate Participants; (ii) determine the 
  

 3 

 type or types of Options to be granted to a Participant; (iii) determine the number of Option Shares to be covered by, or
with respect to which payments, rights, or other matters are to be calculated in connection with, Options; (iv) determine the terms and conditions of any Option; (v) determine whether, to what extent, and under what circumstances Options may be
settled or exercised in cash, Option Shares, other securities, other Options or other property, or canceled, forfeited, or suspended and the method or methods by which Options may be settled, exercised, canceled, forfeited, or suspended; (vi)
determine whether, to what extent, and under what circumstances cash, Option Shares, other securities, other Options, other property, and other amounts payable with respect to an Option shall be deferred either automatically or at the election of
the holder thereof or of the Committee; (vii) interpret, administer, reconcile any inconsistency, correct any default and/or supply any omission in the Plan and any instrument or agreement relating to, or Option made under, the Plan; (iv) establish,
amend, suspend or waive such rules and regulations and appoint such agents as it shall deem appropriate for the proper administration of the Plan; and (ix) make any other determination and take any other action that the Committee deems necessary or
desirable for the administration of the Plan. 
  
 (b) Unless
otherwise expressly provided in the Plan and subject to the terms of any Award Agreement, all designations, determinations, interpretations and other decisions under or with respect to the Plan or any Option shall be within the sole discretion of
the Committee, may be made at any time and shall be final, conclusive and binding upon all Persons, including the Company, any Affiliate, any Participant, any holder or beneficiary of any Option, and any holder of Option Shares. 
  
 (c) No member of the Committee shall be liable for any action or
determination made in good faith with respect to the Plan or any Option hereunder. 
  
 SECTION 4. Shares Available for Options. (a) Subject to adjustment as provided in Section 4(b), the aggregate number of Option Shares with respect to which Options may be granted under the Plan shall equal
32,277. If, after the effective date of the Plan, any Option Shares covered by an Option granted under the Plan, or to which such an Option relates, are forfeited, or if an Option has expired, terminated or been cancelled for any reason whatsoever
(other than by reason of exercise or vesting), then the Option Shares covered by such Option shall again be, or shall become, Option Shares with respect to which Options may be granted hereunder. 
  
 (b) Adjustments. In the event that the Committee determines that any
Sale of the Company, dividend or other distribution (whether in the form of cash, Option Shares, other securities, or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, spin-off,
combination, repurchase, or exchange of Option Shares or other securities of the Company, issuance of warrants (other than to creditors) or other rights to purchase Option Shares or other securities of the Company, or other similar corporate
transaction or event affects the Option Shares such that an adjustment is determined by the Committee in its discretion to be necessary or appropriate in order to prevent dilution or 
  

 4 

 enlargement of the benefits or potential benefits intended to be made available under the Plan, then the Committee shall,
in such manner as it in good faith deems equitable, adjust any or all of (i) the number of Option Shares or other securities of the Company (or number and kind of other securities or property) with respect to which Options may be granted, (ii) the
number of Option Shares or other securities of the Company (or number and kind of other securities or property) subject to outstanding Options, and (iii) the exercise price with respect to any Option. 
  
 (c) Substitute Options. Options may be granted, in the discretion of
the Committee, under the Plan in assumption of, or in substitution for, outstanding awards previously granted by a company acquired by the Company or with which the Company combines (“Substitute Options”). The number of Option Shares
underlying any Substitute Options shall be counted against the aggregate number of Option Shares available for Options under the Plan. 
  
 (d) Sources of Option Shares Deliverable Under Options. Any Option Shares delivered pursuant to an Option may consist, in whole or in part, of
authorized and unissued Common Stock or of treasury shares. 
  
 SECTION 5. Eligibility. Any officer or key employee of the Company or any of its Subsidiaries shall be eligible to be designated a Participant. 
  

SECTION 6. Stock Options. 
  
 (a) Grant. Subject to the provisions of this Plan, the Committee shall have sole and complete authority to determine the Participants to whom
Options shall be granted, the number of Option Shares to be covered by each Option, the exercise price therefor and the conditions and limitations applicable to the exercise of the Option. 
  
 None of the Options granted under the Plan are intended to meet the
requirements of Section 422 of the Code or any successor provision thereto unless such intent is stated explicitly in the Award Agreement; provided, that the Committee shall have the authority to grant Options that are intended to meet the
requirements of Section 422 of the Code or any successor provision thereto. Unless otherwise provided in the applicable Award Agreement, all Options granted by the Committee shall expire ten years after the date such Options are granted. 

 
 (b) Exercise Price. The Committee shall establish the exercise
price at the time each Option is granted, which exercise price shall be set forth in the applicable Award Agreement and shall be not less than the Fair Market Value as of the date of grant. 
  
 (c) Exercise. Each Option shall be exercisable at such times and
subject to such terms and conditions as the Committee may, in its sole discretion, specify in the applicable Award Agreement or, with the consent of the Participant thereafter. The Committee may impose such conditions with respect to the exercise of
Options, including without limitation, any relating to the application of federal or state securities laws, as it may deem necessary or advisable. 
  

 5 

 (d) Vesting. Unless otherwise provided in the applicable Award Agreement, all Options granted by
the Committee shall vest over a five year period, in five equal annual installments beginning on the first anniversary of the date of grant; provided that in no event shall such Options vest over greater than a five year period. If, for any
reason, a Participant is terminated from employment by the Company or any of its Subsidiaries, all unvested Options shall be cancelled. Unless otherwise provided in the applicable Award Agreement, all vested Options not exercised within ninety (90)
days following termination shall be cancelled, unless such Participant has been terminated by the Company for Cause, in which case such vested Options shall immediately be cancelled upon termination. Unless otherwise provided in the applicable Award
Agreement, if the Participant’s employment is terminated other than by the Company for Cause, the Company will provide notice to such Participant setting forth the Fair Market Value of the Common Stock underlying such Options within ninety (90)
days after such termination. 
  
 (e) Payment. No Option
Shares shall be delivered pursuant to any exercise of an Option until payment in full of the aggregate exercise price therefor is received by the Company. Such payment shall be made (i) in cash or by bank check, (ii) after a Public Offering, through
simultaneous sales of underlying Option Shares by brokers, or (iii) in Option Shares or other shares of Common Stock which have been owned by the Participant for at least six months, such Option Shares and/or shares of Common Stock to be valued at
their Fair Market Value as of the date of exercise. 
  
 SECTION 7.
Amendment and Termination. 
  
 (a) Amendments to the
Plan. The Board may amend, alter, suspend, discontinue or terminate the Plan or any portion thereof at any time; provided that any such amendment, alteration, suspension, discontinuance or termination that would materially impair the
rights of any Participant or any holder or beneficiary of any Option theretofore granted shall not to that extent be effective without the consent of the affected Participant, holder or beneficiary. 
  
 (b) Amendments to Options. The Committee may waive any conditions or
rights under, amend any terms of, or alter any Option theretofore granted, prospectively or retroactively; provided that any such waiver, amendment or alteration that would impair the rights of any Participant or any holder or beneficiary of
any Option theretofore granted shall not to that extent be effective without the consent of the affected Participant, holder or beneficiary. In addition, with the consent of any Participant, holder or beneficiary, the Company may suspend,
discontinue, cancel or terminate any Option theretofore granted, prospectively or retroactively. 
  

 6 

 SECTION 8. Sale of the Company. In the event of a Sale of the Company, the Committee may (i)
terminate without payment of any kind any Vested Options that have an exercise price in excess of the Fair Market Value per share of Common Stock (measured as of the date of such Sale of the Company), or (ii) terminate any Vested Options for a
payment in such form and for such amount as the Committee may determine over such Option’s exercise price, multiplied by the number of Options to be terminated, and/or (iii) immediately vest any unvested Options, causing such Options to become
immediately exercisable for, and, subject to the provisions herein and in the applicable Award Agreement, relating to, Option Shares. 
  
 SECTION 9. General Provisions. 
  
 (a) Nontransferability. Options may not be transferred other than by will or the laws of descent and distribution and, during the lifetime of the
Participant, may be exercised only by such Participant (or his legal guardian or legal representative). In the event of the death of a Participant, exercise of Options granted hereunder shall be made only: 
  

	 	i.	by the executor or administrator of the estate of the deceased Participant or the Person or Persons to whom the deceased Participant’s rights under the Option shall pass by
will or the laws of descent and distribution; and 

  

	 	ii.	to the extent that the deceased Participant was entitled thereto at the date of his death, unless otherwise provided by the Committee in such Participant’s Award Agreement.

  
 (b) No Rights to Options. No Participant
or other Person shall have any claim to be granted any Option, and there is no obligation for uniformity of treatment of Participants, or holders or beneficiaries of Options. The terms and conditions of Options and the Committee’s
determinations and interpretations with respect thereto need not be the same with respect to each Participant (whether or not such Participants are similarly situated). 
  
 (c) Share Certificates. All certificates for Option Shares or other securities of the Company delivered under the
Plan pursuant to any Option or the exercise thereof shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations, and other requirements of the SEC, any stock exchange upon
which such Option Shares or other securities are then listed, any applicable federal or state laws, and any applicable written agreements between THL, and/or the Company and the Participants and the Committee may cause a legend or legends to be put
on any such certificates to make appropriate reference to such restrictions. 
  

 7 

 (d) Withholding. 
  
 (i) The Company shall be entitled, if necessary or desirable, to withhold from any Participant, from any amounts due and
payable by the Company to such Participant (or secure payment from such Participant in lieu of withholding), the statutory minimum amount of any withholding or other tax due from the Company with respect to any securities issuable under the Options,
and the Company may defer the exercise of the Options or the issuance of the Option Shares thereunder unless indemnified to its satisfaction. 
  
 (ii) Notwithstanding any provision of this Plan to the contrary, in connection with the transfer of an Option to a transferee pursuant to Section 9(a) of
the Plan, the grantee shall remain liable for any withholding taxes required to be withheld upon the exercise of such Option by the transferee. 
  
 (e) Award Agreements. Each Option hereunder shall be evidenced by an Award Agreement, which shall be delivered to the Participant and shall specify
the terms and conditions of the Option and any rules applicable thereto, including but not limited to the effect on such Option of the death, disability or termination of employment or service of a Participant, and the effect, if any, of such other
events as may be determined by the Committee. 
  
 (f) No Limit
on Other Compensation Arrangements. Nothing contained in the Plan shall prevent the Company or any Affiliate from adopting or continuing in effect other compensation arrangements, which may, but need not, provide for the grant of options
(subject to stockholder approval if such approval is required), and such arrangements may be either generally applicable or applicable only in specific cases. 
  

(g) No Right to Employment. The grant of an Option shall not be construed as giving a Participant the right to be retained in the employ of, or
in any consulting relationship to, the Company or any Affiliate. Further, the Company or an Affiliate may at any time dismiss a Participant from employment or discontinue any consulting relationship, free from any liability or any claim under the
Plan, unless otherwise expressly provided in the Plan or in any Award Agreement. 
  
 (h) No Rights as Stockholder. Subject to the provisions of the applicable Option, no Participant or holder or beneficiary of any Option shall have any rights as a stockholder with respect to any Option Shares
to be distributed under the Plan until he or she has become the holder of such Option Shares. 
  
 (i) Governing Law. The validity, construction, and effect of the Plan and any rules and regulations relating to the Plan and any Award Agreement shall be determined in accordance with the laws of the State of
Delaware applicable to contracts made and to be performed therein. 
  
 (j) Severability. If any provision of the Plan or any Option is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any Person or 
  

 8 

 Option, or would disqualify the Plan or any Option under any law deemed applicable by the Committee, such provision shall
be construed or deemed amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee, materially altering the intent of the Plan or the Option, such provision shall be
stricken as to such jurisdiction, Person or Option and the remainder of the Plan and any such Option shall remain in full force and effect. 
  
 (k) Other Laws. The Committee may refuse to issue or transfer any Option Shares or other consideration under an Option if, acting in its sole
discretion, it determines that the issuance or transfer of such Option Shares or such other consideration will violate any applicable law or regulation or entitle the Company to recover the same under Section 16(b) of the Exchange Act, and any
payment tendered to the Company by a Participant, other holder or beneficiary in connection with the exercise of such Option shall be promptly refunded to the relevant Participant, holder or beneficiary. Without limiting the generality of the
foregoing, no Option granted hereunder shall be construed as an offer to sell securities of the Company, and no such offer shall be outstanding, unless and until the Committee in its sole discretion has determined that any such offer, if made, would
be in compliance with all applicable requirements of the U.S. federal and any other applicable securities laws. 
  
 (l) No Trust or Fund Created. Neither the Plan nor any Option shall create or be construed to create a trust or separate fund of any kind or a
fiduciary relationship between the Company or any Affiliate and a Participant or any other Person. To the extent that any Person acquires a right to receive payments from the Company or any Affiliate pursuant to an Option, such right shall be no
greater than the right of any unsecured general creditor of the Company or any Affiliate. 
  
 (m) Headings. Headings are given to the sections and subsections of the Plan solely as a convenience to facilitate reference. Such headings shall not be deemed in any way material or relevant to the
construction or interpretation of the Plan or any provision thereof. 
  
 SECTION 10. Term of the Plan. 
  
 (c)
Effective Date. The Plan shall be effective as of the date of its approval by the persons and/or entities who own more than 75% of the voting power of all outstanding stock of the Company, determined in a manner consistent with Section
280G(b)(5) of the Code, as amended, and the proposed regulations promulgated thereunder. If such approval is not obtained, this Plan and any Options granted under the Plan shall be null and void and of no force and effect. 
  
 (d) Expiration Date. No Option shall be granted under the Plan after
ten years. Unless otherwise expressly provided in the Plan or in an applicable Award Agreement, the authority of the Board or the Committee to amend, alter, adjust, suspend, discontinue, or terminate any such Option or to waive any conditions or
rights under any such Option shall, continue after ten years from November 20, 2003. 
  

 9 

 SECTION 11. Indemnification. In addition to such other rights of indemnification as they may have
as members of the Board or the Committee, the members of the Board and the Committee shall be indemnified by the Company against all costs and expenses reasonably incurred by them in connection with any action, suit or proceeding to which they or
any of them may be party by reason of any action taken or failure to act under or in connection with the Plan or any Option granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by
independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding; provided that any such Board or Committee member shall be entitled to the indemnification rights set
forth in this Section 11 only if such member has acted in good faith and in a manner that such member reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no
reasonable cause to believe that such conduct was unlawful, and further provided that upon the institution of any such action, suit or proceeding a Board or Committee member shall give the Company written notice thereof and an opportunity, at its
own expense, to handle and defend the same before such Board or Committee member undertakes to handle and defend it on his own behalf. 
  

 10Supply Agreement by and between Mannatech and a supplier

 Exhibit 10.1 
  
 ***Indicates omitted material that is the subject of a confidential treatment request filed separately with the Commission.

  
 SUPPLY AGREEMENT 
  
 This Supply Agreement (“Supply Agreement”) is effective as of March
29, 2004 and is between MANNATECH, INC. a Texas corporation (“MANNATECH”) with its principal place of business located at 600 S. Royal Lane, Suite 200, Coppell, Texas 75019 and ITS SUPPLIER (***) with its principal place of business
located at ***, hereinafter collectively referred to as “Parties”. 
  
 W I T N E S S E T H 
  
 WHEREAS, MANNATECH manufactures and sells a range of dietary supplements for consumers in the United States, Australia, New Zealand, Canada, Japan and the United Kingdom; 
  
 WHEREAS, ITS SUPPLIER sources, processes and freeze-dries a wild bush dried powder native to Australia (the
“Powder”) which may be used as an ingredient in MANNATECH’s Dietary Supplements; 
  
 WHEREAS, IT’S SUPPLIER has made a provisional patent application in Australia for an invention known as a fruit processing device; 
  
 WHEREAS, ITS SUPPLIER desires to sell to MANNATECH and MANNATECH desires to
purchase from ITS SUPPLIER, the Powder for inclusion in its existing and new product lines in quantities, at the price and upon the terms and conditions set forth herein; and between the Parties pursuant to which on the terms and conditions set out
in this agreement. 
  
 NOW, THEREFORE, in consideration of the
premises and mutual covenants and agreements contained herein, the Parties hereto agree as follows: 
  

	1.	Term. 

  

	 	1.1	Initial Term 

  
 This Agreement commences on the effective date above, subject to the terms and conditions of this Agreement and continues in full force and effect for
five (5) years during the Initial Term. 
  

	 	1.2	Renewal 

  
 ITS SUPPLIER grants to MANNATECH an option to renew this Agreement for a further period of five (5)—one (1) year renewal terms on the same terms and
conditions, with the exception of this clause, such option to be exercisable by MANNATECH by notice in writing given not less than three (3) months prior to the expiration of the Initial Term. 
  

	2.	Sale and Purchase. 

  

	 	2.1	ITS SUPPLIER will supply the Powder consistent with the attached Raw Material and Starting Material specifications as indicated and attached hereto as Exhibits “A” and
“B”, respectively, such specifications may be amended from time-to-time as mutually agreed upon by the Parties hereto. 

  

	 	2.2	Subject to the terms and conditions of this Agreement, ITS SUPPLIER shall sell to MANNATECH and MANNATECH shall purchase from ITS SUPPLIER, not less than 1,000 kilograms of Powder
per year during the Term (the “Minimum Amount”). In the event that MANNATECH reasonably anticipates that it shall require more Powder than its prior order, ITS SUPPLIER will exert its best reasonable effort to deliver such additional
amounts. 

  

	 	2.3	ITS SUPPLIER shall be responsible for making arrangements to ensure that the harvesting and supply of raw materials is legal in Australia and that the export of Powder from
Australia is legal at all times, subject to Article 18. 

  

 1 

	3.	Forecast and Reserve Amount. 

  
 ITS SUPPLIER will guarantee the continuity of supply based on Mannatech’s demand. Mannatech, to the best of its abilities will provide a one (1) year
forecast of its anticipated Powder requirements (the “Forecast”). The Forecast will be prepared in October for the following calendar year. Mannatech will work with ITS SUPPLIER to develop a level of safety stock based on seasonal crop
variations (the “Reserve Amount”). ITS SUPPLIER will carry safety stock, at an agreed level, in excess of any stock ordered by Mannatech and will notify Mannatech, in writing, immediately upon discovering that it may not be able to meet
Mannatech’s demand, for any reason whatsoever. 
  

	4.	Minimum Purchase. 

  

	 	4.1	MANNATECH is not obligated to purchase the Forecast Amount or the Reserve Amount; however MANNATECH agrees to order and ITS SUPPLIER agrees to supply the Minimum Amount.

  

	 	4.2	If MANNATECH orders less than the Minimum Amount, MANNATECH agrees to pay ITS SUPPLIER at the end of the calendar year the difference between the price of the amount ordered in the
calendar year and the price of the Minimum Amount. 

  

	 	4.3	If ITS SUPPLIER is unable, or anticipates it will be unable to supply the Powder, ITS SUPPLIER will immediately notify MANNATECH in writing that it is unable to supply the Powder
and will arrange for the refund of all outstanding pre-payments within fifteen (15) calendar days of notification. 

  

	5.	Order & Delivery. 

  

	 	5.1	MANNATECH to place orders 

  
 MANNATECH will place orders for the Powder with ITS SUPPLIER from time-to-time (“Orders”). Orders must be in writing and specify: 
  

	 	(a)	the quantity of Powder required; 

  

	 	(b)	the port of shipment and details of the relevant ship; and 

  

	 	(c)	the delivery date. 

  

	 	5.2	Rejection of order 

  
 ITS SUPPLIER may only reject an Order from MANNATECH if: 
  

	 	(a)	ITS SUPPLIER has supplied the Minimum Amount in the calendar year; 

  

	 	(b)	ITS SUPPLIER has supplied the Forecast and Reserve Amount for the calendar year; and 

  

	 	(c)	ITS SUPPLIER does not have any remaining Powder (including any Reserve Amount). 

  

	 	5.3	Delivery 

  
 MANNATECH and ITS SUPPLIER agree that ITS SUPPLIER will deliver the Powder to MANNATECH at 445 S. Royal Lane, Suite 600, Coppell, Texas 75019 USA.
MANNATECH agrees that it will identify in the Order, the port of shipment to the USA of the Powder and MANNATECH will pay or reimburse ITS SUPPLIER for the cost of shipment from the Australian port of shipment to the warehouse in the USA nominated
by MANNATECH. 
  

	6.	Price & Payment. *** (This pricing structure has been omitted pursuant to a request for confidential treatment and the material has been filed with the
Commission separately.) 

  

	 	6.1	The Parties agree that for the first year of the Term, ITS SUPPLIER will sell the Powder to MANNATECH at a price of ***. (“Price”). All payment shall be in
Australian dollars. 

  

	 	6.2	MANNATECH will pay fifty percent (50%) of total invoice at the time the Order is placed. Final payment is due within fifteen (15) business days after MANNATECH accepts or is deemed
to have accepted the compliance of the powder as in Article 7 hereof. 

  

 2 

	 	6.3	The Parties agree that, at least thirty (30) days prior to the twelve month period ending each year after the effective date and each Renewal Term thereafter, (the “Anniversary
Date”), MANNATECH and ITS SUPPLIER will agree in writing on the price of the Powder to be sold by ITS SUPPLIER and purchased by MANNATECH hereunder during such additional one-year period. At least sixty (60) days prior to the Anniversary Date,
ITS SUPPLIER and MANNATECH shall commence good faith negotiations to determine and agree upon such Price for such additional one-year period. The foregoing notwithstanding, in no event shall the Price exceed *** per kg. If MANNATECH and ITS
SUPPLIER are unable to so agree on such Price, the Parties may terminate this Agreement at the end of the then-current Term. Nothing contained in this Paragraph shall be deemed to (i.) obligate MANNATECH and ITS SUPPLIER to agree upon such Price,
(ii.) obligate a party to negotiate with the other party regarding such Price if the other party is then in breach of or in default under this Agreement or (iii) limit the rights of MANNATECH and ITS SUPPLIER under Article 18 hereof.

  

	7.	Inspection & Non-Compliance. 

  

	 	7.1	MANNATECH has the right to inspect and test the Powder as contemplated herein, to the extent practicable and at all places and times, including the period of manufacture, and in any
event prior to acceptance thereof. MANNATECH shall perform inspections and tests for quality assurance in a manner that will not unduly delay the production of the Powder. MANNATECH may require repair, reformulation or replacement of non-conforming
Powder, constituting, without limitation of the foregoing, unacceptable manufacture, scientific validation, safety, efficacy and nonconformity with applicable law. MANNATECH reserves the right to run adequate testing, at its sole expense, to
determine whether the Powder conforms to the specifications as contemplated hereby. Use of a portion of the Powder for testing purposes does not constitute acceptance thereof. In the event of a dispute over test results, the arbiter will be the
Australian Government Analytical Laboratories or an FDA certified laboratory in the USA. 

  

	 	7.2	Inspection of Manufacturing Processes 

  
 ITS SUPPLIER will provide reasonable access to nominated representatives of MANNATECH to ITS SUPPLIER’S facilities or subcontracted facilities to
monitor ITS SUPPLIER’S compliance with its obligations under this Agreement and perform any tests deemed necessary to ensure the Powder is manufactured in accordance with the Product Specifications. MANNATECH agrees to ensure its nominated
representatives comply with any reasonable instructions given to the representative by ITS SUPPLIER while the representative is on ITS SUPPLIER’S premises. 
  

	 	7.3	Inspection and Testing of Powder 

  

	 	7.3.1	MANNATECH will inspect the Powder and carry out quality assurance tests (“QAT”) and to ensure compliance with the terms of this Agreement within thirty (30) days of the
Powder being received by MANNATECH at its nominated warehouse in the United States (“Acceptance Period”). If MANNATECH inspects the Powder, carries out the QAT and collects the Powder without notifying ITS SUPPLIER within fourteen (14)
business days of any non-complying Powder, MANNATECH will be deemed to have accepted compliance of the Powder. 

  

	 	7.3.2	If MANNATECH fails to carry out an inspection and the QAT within the Acceptance Period, it is deemed to have accepted compliance of the Powder on the terms of this Agreement.

  

	 	7.4	Non-complying Products 

  
 If during the Acceptance Period: 
  

	 	7.4.1	MANNATECH acting reasonably considers that the Powder delivered to MANNATECH by ITS SUPPLIER does not comply with the Product Specifications or any applicable laws, regulations or
industry standards or does not satisfy the QAT (“Non-Complying Powder”); and 

  

 3 

	 	7.4.2	The relevant non-compliance, in the reasonable opinion of MANNATECH occurred during the manufacture or packaging of the Powder by ITS SUPPLIER, then MANNATECH:

  

	 	(a)	Must immediately notify ITS SUPPLIER of the alleged Non-Complying Powder and the details of the alleged non-compliance (including any relevant test results); and

  

	 	(b)	Isolate all Non-Complying Powder delivered in the same shipment; and 

  

	 	(c)	Allow ITS SUPPLIER (or its agent or representative) to inspect the Non-Complying Powder which has been isolated by MANNATECH. 

  

	 	7.5	Reimbursement of Reasonable Costs 

  
 If IT’S SUPPLIER or its agent or representative 
  

	 	7.5.1	agrees that the Powder isolated by MANNATECH is Non-Complying, it must reimburse the costs incurred by MANNATECH in isolating the Non-Complying Powder, collect the Non-Complying
Powder from MANNATECH and, at ITS SUPPLIER’S option, either 

  

	 	(a)	replace the amount of Non-Complying Powder with complying Powder; or 

  

	 	(b)	if ITS SUPPLIER has already been paid for the Non-Complying Powder, refund an amount equal to the invoiced price of the Non-Complying Powder; or 

  

	 	(c)	if ITS SUPPLIER has not been paid, issue a new invoice to MANNATECH with a reduction in price equal to the invoiced price for the Non-Complying Powder; or 

 

	 	(d)	does not agree with MANNATECH that any of the Non-Complying Powder rejected are non-complying, then the dispute resolution provisions of clause 7.6 shall apply.

  

	 	7.6	Product Conformity Arbitration 

  
 If the Parties cannot agree whether the Powder is non-complying, the Parties may appoint an arbitrator to settle the dispute (the cost of which shall be
equally shared by the Parties) from: 
  

	 	7.6.1	the Australian Government Analytical Laboratories; or 

  

	 	7.6.2	an FDA certified laboratory in the United States nominated by MANNATECH. 

  

	8.	Title & Risk. 

  
 Title and risk in the Powder which is subject to an Order passes from ITS SUPPLIER to MANNATECH when compliance of the Powder is accepted or is deemed to
have been accepted in accordance with clause 7.3 and payment has been made in full. 
  

	9.	Marketing. 

  

	 	9.1	Marketing the Dietary Supplements 

  
 The Parties agree that any Dietary Supplement (or other such product) which has the Powder as an ingredient will be marketed under the MANNATECH
Intellectual Property. 
  

	 	9.2	Product Information. 

  
 ITS SUPPLIER will provide to MANNATECH all reasonably accessible scientific data, safety data, efficacy studies and other relevant information
(“Product Information”) to substantiate any and all of ITS SUPPLIER’S claims about the Powder. 
  

	 	9.3	Marketing the Product 

  
 MANNATECH will use its best endeavors to market the Powder, including without limitation, preparing appropriate marketing materials and training for
MANNATECH’s distributors. 
  

 4 

	10.	Exclusivity. 

  

	 	10.1	During the Term and any Renewal Term of this Agreement, ITS SUPPLIER agrees that it will provide the Powder (for sale or otherwise) only to Mannatech for inclusion in its dietary
supplements worldwide Except as expressly permitted by written approval of Mannatech, ITS SUPPLIER may not sell the Powder to any other company or individual for use in a Dietary Supplement. ITS SUPPLIER may sell excess Powder to other companies
provided it receives written assurances that the Powder will only be used for other than in Dietary Supplements and/or listed medicines and only upon prior written consent of MANNATECH, which will not be unreasonably withheld.

  

	 	10.2	For the purpose of this Agreement “Dietary Supplement” is defined as a finished product, in tablet, capsule or powder form, for nutritional purposes or similar uses as
permitted in the USA under DSHEA; Australia in listed or registered oral complementary medicines as defined in the Therapeutic Goods Act; and similar products in other countries. 

  

	 	10.3	Without limitation of the foregoing, ITS SUPPLIER may not sell Powder in any form or fashion to any of MANNATECH’S Independent Associates. For the purposes of this Agreement,
an Associate is an individual or business entity which has been assigned a MANNATECH account number, is bound by MANNATECH’S Associate Agreement and the terms and conditions related thereto, and which has placed at least one order for MANNATECH
products during the prior twelve (12) month period. For the purposes of this paragraph, “Associates” shall also be defined to include individuals participating in MANNATECH’S “Member” program. 

  

	11.	Quality. 

  
 ITS SUPPLIER warrants to MANNATECH that all Powder sold by ITS SUPPLIER pursuant to this Agreement will conform to the quality specifications set forth in
Exhibits A & B to this Agreement. ITS SUPPLIER REPRESENTS THAT THE POWDER MEETS THE SPECIFICATIONS OUTLINED ON THE ATTACHED EXHIBITS A & B AND THAT IT IS AN INGREDIENT APPROVED FOR USE IN COMPLEMENTARY MEDICINES UNDER
THE THERAPEUTIC GOODS ACT. 
  

	12.	ITS SUPPLIER’S Warranties. 

  
 ITS SUPPLIER warrants to MANNATECH that: 
  

	 	12.1	the Powder will be harvested, processed and packaged so that it meets the Product Specifications; 

  

	 	12.2	the performance of its obligations under this Agreement does not breach any other agreement to which it is a party, including but not limited to, any agreements with its customers
or suppliers; 

  

	 	12.3	ITS SUPPLIER has all necessary licenses, permits and approvals necessary to harvest, process and export Powder to the United States and that such harvesting, processing and
exporting will not contravene any laws or regulations of the Commonwealth of Australia; 

  

	 	12.4	The harvesting, processing and supply of the raw materials complies with all applicable law, regulations and industry standards in Australia; 

  

	 	12.5	The Powder will, when exported comply with all applicable law, regulations and industry standards in Australia; and 

  

	 	12.6	The Powder will not violate or infringe any patent or copyright in Australia and New Zealand or constitute the misuse or misappropriation of any trade secret or confidential
information which is the subject of an agreement or legal requirement involving a third-party. 

  

	13.	Termination. 

  
 Mannatech may terminate this Agreement immediately by written notice to ITS SUPPLIER if: 
  

	 	13.1	A person (other than a person who is a related body corporate of ITS SUPPLIER) directly or indirectly becomes entitled to or acquires more than 50% of the voting shares of ITS
SUPPLIER; 

  

	 	13.2	ITS SUPPLIER disposes of part or all of its assets, operations or business other than in the ordinary course of business (except where that disposal is to a person who is a related
body corporate of ITS SUPPLIER); 

  

 5 

	 	13.3	The Supplier ceases to supply ITS SUPPLIER with wild plums or fails to supply ITS SUPPLIER with sufficient wild plums to enable ITS SUPPLIER to supply the Minimum Amount, in either
case for reasons other than a Force Majeure event; 

  

	 	13.4	Any governmental authority or regulator imposes restrictions on the harvesting, processing or export of the Powder which has the effect that ITS SUPPLIER is not reasonably able to
supply the Minimum Amount; or 

  

	 	13.5	In any year a substantial portion, for example 30%, of Powder supplied by ITS SUPPLIER fails to meet the Product Specifications or to satisfy the QAT, or some of the Powder, for
example 30%, repeatedly fails to meet such Product Specifications or satisfy the QAT. 

  

	14.	Confidential Information. 

  

	 	14.1	ITS SUPPLIER recognizes and acknowledges that MANNATECH’S trade name(s), trademarks, copyrights, patents, marketing plans, identity of and related information regarding its
Associates, product formulations and other proprietary product information and any information relating to the management/operations of MANNATECH are valuable assets belonging to MANNATECH and as such are the sole property and may constitute trade
secrets of MANNATECH. Prior to and during the performance of this Agreement ITS SUPPLIER may have or had access to certain confidential information pertaining to MANNATECH. ITS SUPPLIER specifically agrees ITS SUPPLIER will not at any time, during
or after the performance of the Agreement, in any manner, either directly or indirectly, use, divulge, disclose, or communicate to any person, firm or corporation, any confidential information of any kind, nature, or description concerning any
matters affecting or relating to the business of MANNATECH (hereinafter referred to as “MANNATECH Confidential Information”). MANNATECH Confidential Information includes but is not limited to: MANNATECH genealogies (being the information
held by MANNATECH or by any current or former Associate of MANNATECH related to its Associates including without limitation its relationship with each of its Associates, the Associate’s name, address, telephone number, email address, upline and
downline, charts, data reports, proprietary product information which may from time-to-time be made known to ITS SUPPLIER, the names or practices of any of MANNATECH’S customers or Associates; MANNATECH’S marketing methods and related
data; the names of MANNATECH’S vendors or suppliers; costs of materials; costs of its products generally, the prices MANNATECH obtains or has obtained or at which it sells or has sold its products or services; manufacturing and sales costs;
lists or other written records used in MANNATECH’s business; compensation paid to its Associates, details of training methods, new products or new uses for old products, merchandising or sales techniques, contracts and licenses, business
systems, computer programs, or any other confidential information of, about, or concerning the business of MANNATECH; its manner of operation or other confidential data of any kind, nature or description. 

  

	 	14.2	ITS SUPPLIER agrees to use the MANNATECH Confidential Information only for MANNATECH business and shall return copies of any written MANNATECH Confidential Information in ITS
SUPPLIER’S possession to MANNATECH forthwith upon written demand and upon termination of this Agreement for whatever reason. 

  

	 	14.3	Notwithstanding anything to the contrary contained in this Agreement or the License Agreement, 

  

	 	14.3.1	ITS SUPPLIER shall have no obligation to maintain in confidence or return to MANNATECH any information (i) that was known to ITS SUPPLIER prior to its disclosure to ITS SUPPLIER by
MANNATECH or any of its current or former Associates and that did not become known to ITS SUPPLIER through disclosure by a person who was then known actually by ITS SUPPLIER to have obtained such information or made such disclosure in violation of
any obligation to MANNATECH, (ii) that is now in or hereafter enters the public domain other than due to a breach by ITS SUPPLIER of this paragraph 14, (iii) that is disclosed to ITS SUPPLIER by a third party who is not actually known by ITS
SUPPLIER to have obtained or disclosed such information in violation of any obligation to MANNATECH, or (iv) that is independently developed by ITS SUPPLIER without the aid, application or use of any MANNATECH Confidential information disclosed to
ITS SUPPLIER; and 

  

 6 

	 	14.3.2	ITS SUPPLIER may make any disclosure of MANNATECH Confidential Information (i) that it is necessary or appropriate to make in order to carry out its obligations under any written
agreement with MANNATECH, (ii) that it is required or permitted to make pursuant to any written consent of or written agreement with MANNATECH or (iii) that it is required by law to make. 

  

	 	14.4	MANNATECH recognizes and acknowledges that ITS SUPPLIER’S trade name(s), trademarks, copyrights, patents, marketing plans, product formulations, know-how, compounds, products,
processes, designs, production methods and techniques and other proprietary product information and any information relating to the management/operations of ITS SUPPLIER are valuable assets and confidential information belonging to ITS SUPPLIER and
as such are the sole property of ITS SUPPLIER and may constitute trade secrets of ITS SUPPLIER. Prior to and during the performance of the Agreement, MANNATECH may have or had access to certain confidential information pertaining to ITS SUPPLIER.
MANNATECH specifically agrees it will not at any time, during or after the performance of this Agreement, in any manner, either directly or indirectly, use, divulge, disclose, or communicate to any person, firm or corporation, any confidential
information of any kind, nature, or description concerning any matters affecting or relating to the business of ITS SUPPLIER (hereinafter referred to as “ITS SUPPLIER Confidential Information”). ITS SUPPLIER Confidential Information
includes but is not limited to: the names or practices of any of ITS SUPPLIER’S customers; ITS SUPPLIER’S marketing methods and related data; the names of ITS SUPPLIER’S vendors or suppliers; costs of materials; costs of its products
generally, the prices ITS SUPPLIER obtains or has obtained or at which it sells or has sold its products or services; manufacturing and sales costs; lists or other written records used in ITS SUPPLIER’S business; details of training methods,
new products or new uses for old products, merchandising or sales techniques, contracts and licenses, business systems, computer programs, or any other confidential information of, about, or concerning the business of ITS SUPPLIER; its manner of
operation or other confidential data of any kind, nature or description. 

  

	 	14.5	MANNATECH agrees to use the ITS SUPPLIER Confidential Information only for ITS SUPPLIER business and shall return copies of any written ITS SUPPLIER Confidential Information in its
possession to ITS SUPPLIER forthwith upon written demand and upon termination of this Agreement for whatever reason. 

  

	 	14.6	Notwithstanding anything to the contrary contained in this Agreement, 

  

	 	14.6.1	MANNATECH shall have no obligation to maintain in confidence or return to ITS SUPPLIER any information (i) that was known to MANNATECH prior to its disclosure to MANNATECH by ITS
SUPPLIER that did not become known to MANNATECH through disclosure by a person who was then known actually by MANNATECH to have obtained such information or made such disclosure in violation of any obligation to ITS SUPPLIER, (ii) that is now in or
hereafter enters the public domain other than due to a breach by MANNATECH of this paragraph 14, (iii) that is disclosed to MANNATECH by a third party who is not actually known by MANNATECH to have obtained or disclosed such information in violation
of any obligation to ITS SUPPLIER, or (iv) that is independently developed by MANNATECH without the aid, application or use of any ITS SUPPLIER Confidential information disclosed to MANNATECH; and 

  

	 	14.6.2	MANNATECH may make any disclosure of ITS SUPPLIER Confidential Information (i) that it is necessary or appropriate to make in order to carry out its obligations under any written
agreement with ITS SUPPLIER, (ii) that it is required or permitted to make pursuant to any written consent of or written agreement with ITS SUPPLIER or (iii) that it is required by law to make. 

  

	15.	No Agency. 

  
 Nothing contained or implied in this Agreement constitutes a party the partner, agent or legal representative of another party for any purpose or creates
any partnership, agency or trust, and no party has any authority to bind the other party in any way. 
  

 7 

	16.	Disclaimer and Indemnity. 

  
 ITS SUPPLIER shall defend, indemnify and hold harmless MANNATECH and its affiliates, and respective officers, directors, employees and agents, from and
against all claims, liabilities, demands, damages, expenses and losses (including reasonable attorneys’ fees and expenses) arising out of or connected with any breach by ITS SUPPLIER of any of its obligations under this Agreement. 

 

	17.	Force Majeure. 

  
 ITS SUPPLIER shall not have any liability hereunder if it shall be prevented from performing any of its obligations hereunder by reason of any factor
beyond its control, including without limitation, fire, explosion, accident, riot, flood, drought, storm, earthquake, lightening, frost, civil commotion, sabotage, vandalism, smoke, hail, embargo, act of God or the public enemy, other casualty,
strike or lockout, interference, prohibition or restriction imposed by any government or any officer or agent, or a change in the policy of the traditional landowners thereof (“Force Majeure”), and ITS SUPPLIER’S obligations, so far
as may be necessary, shall be suspended during the period of such Force Majeure and shall be cancelled in respect of such quantities of Powder as would have been sold hereunder but for such suspension. ITS SUPPLIER shall give MANNATECH prompt notice
of any such Force Majeure, the date of commencement thereof and its probable duration and shall give a further notice in like manner upon termination thereof. Each party hereto shall endeavor with due diligence to resume compliance with its
obligations hereunder at the earliest date and shall do all that it reasonably can to overcome or mitigate the effects of any such Force Majeure upon its obligations under this Agreement. 
  

	18.	Rights Upon Default. 

  

	 	18.1	ITS SUPPLIER’S Rights Upon Default. 

  
 If MANNATECH (i.) fails to purchase the quantities of Powder specified for purchase by MANNATECH hereunder, (ii.) fails to make a payment hereunder when
due, or (iii.) otherwise breaches any term of this Agreement, and such failure or breach is not cured to ITS SUPPLIER’S reasonable satisfaction within fifteen (15) business days (in the case of a failure to make a payment) or thirty (30)
calendar days (in any other case) after receipt of notice thereof by MANNATECH, or if MANNATECH fails to perform or observe any covenant or condition on its part to be performed or observed when required to be performed and observed, and such
failure continues after the applicable grace period, if any, specified in this Agreement, ITS SUPPLIER may refuse to make further deliveries hereunder and may terminate this Agreement upon notice to MANNATECH, and in addition, shall have such other
rights and remedies, including the right to recover damages, as are available to ITS SUPPLIER under applicable law or otherwise. 
  
 18.2 MANNATECH’S Rights Upon Default. 
  
 If ITS SUPPLIER fails in any material respect to perform its obligations hereunder, and such failure is not cured to MANNATECH’S reasonable
satisfaction within thirty (30) calendar days after notice thereof by MANNATECH, MANNATECH shall have the right to refuse to accept further deliveries hereunder and to terminate this Agreement upon notice to ITS SUPPLIER, and in addition, shall have
such other rights and remedies, including the right to recover damages, as are available to MANNATECH under applicable law or otherwise. Any subsequent delivery of Powder to MANNATECH after any default by ITS SUPPLIER under this Agreement shall not
constitute a waiver of any rights of MANNATECH arising out of such prior default; nor shall MANNATECH’S failure to insist upon strict performance of any provision of this Agreement be deemed a waiver by MANNATECH of any of its rights or
remedies hereunder or under applicable law or a waiver by MANNATECH of any subsequent default by ITS SUPPLIER in the performance of or compliance with any of the terms of this Agreement. 
  

	19.	Further Assurances. 

  
 The Parties shall execute and deliver such additional documents and take such additional actions as either Party may reasonably deem to be necessary or
appropriate to more fully consummate the transactions contemplated by and affect the purposes of this Agreement. All such additional documents and actions shall be deemed to have been executed, delivered or taken on the date of this Agreement,
except as may otherwise be appropriate. 
  

 8 

	20.	Authority. 

  
 The Parties represent that they have full capacity and authority to grant all rights and assume all obligations they have granted and assumed under this
Agreement. 
  

	21.	Succession. 

  
 The Parties hereto may not assign or otherwise transfer this Agreement or any of its rights or obligations hereunder (including, without limitation, by
merger or consolidation) without the prior written consent of the other party. Subject to the immediately preceding sentence, this Agreement shall be binding upon and inure to the benefit of the Parties hereto and their respective successors and
assigns. 
  

	22.	Notices. 

  
 All notices and other communications with respect to this Agreement shall be in writing and shall be deemed to have been duly given when delivered
personally or three (3) days following deposit in the mails, first class mail, postage prepaid, to the address set forth below, or such other address hereafter specified in like manner by one Party to the other: 
  

			
	If to MANNATECH:	 	 600 S. Royal Lane, #200
  
 Coppell, Texas 75019
  
 Attention: General Counsel
  

	If to ITS SUPPLIER:	 	***

  

	23.	Applicable Law; Venue. 

  
 This Agreement shall be governed by and construed in accordance with the laws of New South Wales, Australia. Venue of any action brought to enforce or
interpret this Agreement shall only be New South Wales, Australia. 
  

	24.	Interpretation. 

  
 If any provision of this Agreement is held to be illegal, invalid or unenforceable under present or future laws, such provision shall be fully severable
and the remaining provisions hereof shall remain in full force and effect and shall not be affected by the illegal, invalid or unenforceable provision or by its severance from this Agreement. Furthermore, in lieu of such illegal, invalid or
unenforceable provision, there shall be added as part of this Agreement, a provision as similar in its terms to such illegal, invalid or unenforceable provision as may be possible and be legal, valid and enforceable. 
  

	25.	No Inconsistent Actions. 

  
 Each party hereto agrees that it will not voluntarily undertake any action or course of action inconsistent with the provisions or intent of this
Agreement and will promptly do all acts and take all measures as may be appropriate to comply with the terms, conditions and provisions of this Agreement. 
  

	26.	Survival. 

  
 The expiration or termination of the Term shall not impair the rights or obligations of the Parties which have accrued hereunder prior to such expiration
or termination. The provisions of Paragraphs 12, 16, and 18 hereof, and the rights and obligations of the Parties thereunder, shall survive the expiration or termination of the Term. 
  

	27.	Entire Agreement. 

  
 Except as otherwise contemplated hereby, this Agreement and constitute the entire agreement of the Parties, and supersedes all prior agreements and
understandings (oral and written), between or among the parties with respect to the subject matter hereof. 
  
 [Signature Page Follows] 
  

 9 

 ACCEPTED AND AGREED. 
  
 This Agreement may be executed in one or more counterparts, each of which will be deemed an original but all of which together will constitute one and the same document.

  
 EXECUTED on behalf of the corporation named

 below by the authorised person(s) whose signature 
 appears below pursuant to the authority specified. 
 Corporation: *** (IT’S SUPPLIER) 
 Authority: Section 127 of the Corporations Law (Australia) 
  

			
	                 ***

	 	                 ***

	 Signature of authorised person
	 	Signature of authorised person
		
	                 ***

	 	                 ***

	 Name of authorised person
	 	Name of authorised person
		
	 Office held: DIRECTOR
	 	Office held: DIRECTOR

  
 EXECUTED on behalf of the corporation named 
 below by the authorised person(s) whose signature 
 appears below pursuant to the authority specified. 
 Corporation: MANNATECH, INC. 
 Authority: Section 127 of the Corporations Law (Australia) 
  

			
	 /s/ Terry Persinger

	 	 /s/ Jeff Bourgoyne

	 Signature of authorised person
	 	Signature of authorised person
		
	 March 26, 2004
	 	March 29, 2004
	 Terry Persinger
	 	Jeff Bourgoyne
	 Office held: President
	 	Office held: Senior Vice-President

  

 10 

 Exhibit A 
  

Raw Material Technical Specifications 
 as of February 19, 2003 
  

					
	 Department: Technical
	    	RM 101	    	Page 1 of 1
	 Subject: Australian Bush Plum Powder
	    	 	    	Version No: 1

  

	1.	Botanical Name 

  
 *** 
  

	2.	Common Names 

  
 *** 
  

	3.	Geographical Source 

  
 *** 
  

	4.	Plant Part Used 

  
 *** 

	5.	Type of Preparation 

  
 *** 
  

	6.	Characteristics 

  

	 	6.1	General Appearance (TM 101) 

  
 *** 
  

	 	6.2	Organoleptic Properties (TM 102) 

  
 *** 
  

	 	6.3	Moisture Content (TM 103) 

  
 *** 
  

	 	6.4	Total Ash (TM 104) 

  
 *** 
  

	 	6.5	Heavy Metals (TM 105) 

  
 *** 
  

	 	6.6	Partical Size (TM 106) 

  
 *** 
  

	 	6.7	Ascorbic Acid Content (TM 107) 

  
 *** 
  

	 	6.8	Organochlorine, Organophosphorus Fungicides and Herbicides Residues (TM 108) 

  
 *** 
  

	 	6.9	Microbial Limits * 

  
 ** 
  
 Presence of E. coli – not detected in 1g 
 Presence of Salmonella spp. – not detected in 10g 
  
 End of Document 
  
 Commercial in Confidence 
  

 1 

 Exhibit B 
  

Raw Material Technical Specifications 
 as of February 19, 2003 
  

					
	 Department: Technical
	    	SM 101	    	Page 1 of 1
	 Subject: Australian Bush Plum
	    	 	    	Version No: 1

  

	1.	Botanical Name 

  
 *** 
  

	2.	Common Names 

  
 *** 
  

	3.	Plant Part Used 

  
 *** 
  

	4.	Geographical Distribution 

  
 *** 
  

	5.	Description 

  
 *** 
  

	6.	Characteristics 

  

	 	6.1	Plant Part 

  
 *** 
  

	 	6.2	General Appearance 

  
 *** 
  

	 	6.3	Organoleptic Properties 

  
 *** 
  

	 	6.4	Cleanliness 

  
 *** 
  

	 	6.5	Purity 

  
 *** 
  

	 	6.6	Organochlorine, Organophosphorus Fungicides and Herbicides 

  
 *** 
  

	 	6.7	Ascorbic Acid Content 

  
 *** 
  
 End of Document 
  
 Commercial in Confidence 
  

 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00081-of-00352.parquet"}]]